|
EIF1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65445435129641E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65978342181461E-12 |
| Normal-vs-Stage2 |
3.49720030712319E-10 |
| Normal-vs-Stage3 |
3.29040000024428E-07 |
| Normal-vs-Stage4 |
7.84000000475515E-08 |
| Stage1-vs-Stage2 |
6.268200E-01 |
| Stage1-vs-Stage3 |
4.325000E-01 |
| Stage1-vs-Stage4 |
7.798200E-01 |
| Stage2-vs-Stage3 |
2.641000E-01 |
| Stage2-vs-Stage4 |
9.248800E-01 |
| Stage3-vs-Stage4 |
4.179600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.98549998664532E-09 |
| Normal-vs-Asian |
7.398500E-02 |
| Caucasian-vs-AfricanAmerican |
3.934400E-01 |
| Caucasian-vs-Asian |
4.759200E-01 |
| AfricanAmerican-vs-Asian |
8.524400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.26349999854492E-08 |
| Male-vs-Female |
3.321600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.01740002270645E-09 |
| Normal-vs-Extreme_Weight |
1.63991042967382E-12 |
| Normal-vs-Obese |
2.97200042354007E-11 |
| Normal-vs-Extreme_Obese |
1.36490000413048E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.151600E-01 |
| Normal_Weight-vs-Obese |
8.447400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.509800E-01 |
| Extreme_Weight-vs-Obese |
4.940600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.026600E-01 |
| Obese-vs-Extreme_Obese |
3.989400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.56220000002705E-06 |
| Normal-vs-Age(41-60Yrs) |
1.76025860554319E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.44909999999498E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.248000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.323220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.651000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.390600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.880800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.916200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.26939578240604E-11 |
| Normal-VS-KIRP CIMP |
1.738630E-03 |
| Normal-VS-Unclassified PRCC |
1.67399427652981E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.035010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.940300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.005600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.887770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.328800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.643800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.61410000207607E-08 |
| Normal-vs-N1 |
2.81640266663885E-11 |
| Normal-vs-N2 |
5.90579999999452E-05 |
| N0-vs-N1 |
8.258800E-01 |
| N0-vs-N2 |
7.024600E-01 |
| N1-vs-N2 |
5.156000E-01 |
|
|
